IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $711,118 | -33.6% | 111,286 | -0.5% | 0.01% | -40.0% |
| Q3 2022 | $1,071,000 | -24.5% | 111,850 | -13.0% | 0.01% | -9.1% |
| Q2 2022 | $1,419,000 | -24.6% | 128,551 | +13.6% | 0.01% | 0.0% |
| Q1 2022 | $1,883,000 | -5.7% | 113,113 | +8.1% | 0.01% | +10.0% |
| Q4 2021 | $1,997,000 | -15.0% | 104,596 | +9.8% | 0.01% | -28.6% |
| Q3 2021 | $2,350,000 | -7.9% | 95,299 | -2.8% | 0.01% | -6.7% |
| Q2 2021 | $2,551,000 | -9.9% | 98,060 | +9.7% | 0.02% | -21.1% |
| Q1 2021 | $2,831,000 | -12.1% | 89,422 | +28.9% | 0.02% | -5.0% |
| Q4 2020 | $3,220,000 | +18.3% | 69,398 | -16.0% | 0.02% | 0.0% |
| Q3 2020 | $2,721,000 | -12.0% | 82,641 | -26.6% | 0.02% | -16.7% |
| Q2 2020 | $3,091,000 | – | 112,602 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |